Drug intelligence / Profile preview

Myco subunit vaccine

Development stage: Preclinical
Lead developer: Reber Genetics
Modality: Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration: Intramuscular

Overview

Myco subunit vaccine is a veterinary vaccine candidate being developed by Reber Genetics for the prevention of Mycoplasma infections in swine. The vaccine utilizes a subunit platform based on cancer immunotherapy principles to deliver specific Mycoplasma antigens, designed to induce a protective immune response. Mycoplasma species, particularly *Mycoplasma hyopneumoniae*, are significant pathogens in the swine industry, contributing to the porcine respiratory disease complex (PRDC) and causing economic losses through reduced growth rates. This subunit approach aims to provide targeted immunity while avoiding the safety concerns associated with live-attenuated vaccines. The product is currently in the preclinical stage of development.

Other names: Mycoplasma subunit vaccine

Beyond the preview

Go deeper on Myco subunit vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myco subunit vaccine.

Explore the full profile